These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37777388)
1. Patient awareness, perceptions, and attitudes towards pharmacists prescribing tobacco cessation medications. Berry J; Hilts KE; Thoma L; Corelli RL; Stump TE; Monahan PO; Hudmon KS Res Social Adm Pharm; 2023 Dec; 19(12):1531-1542. PubMed ID: 37777388 [TBL] [Abstract][Full Text] [Related]
2. Using the Theory of Planned Behavior to assess community pharmacists' intention to prescribe using the Formulary and Protocol Compendia. Wash A; Moczygemba LR; Anderson L; Pye T Res Social Adm Pharm; 2022 Dec; 18(12):4056-4064. PubMed ID: 35864036 [TBL] [Abstract][Full Text] [Related]
4. Pharmacists' intention to prescribe under new legislation. Wash A; Moczygemba LR; Anderson L; Pye T Res Social Adm Pharm; 2022 May; 18(5):2837-2847. PubMed ID: 34244074 [TBL] [Abstract][Full Text] [Related]
5. Update and recommendations: Pharmacists' prescriptive authority for tobacco cessation medications in the United States. Hilts KE; Corelli RL; Vernon VP; Hudmon KS J Am Pharm Assoc (2003); 2022; 62(5):1531-1537. PubMed ID: 35953378 [TBL] [Abstract][Full Text] [Related]
6. Tobacco treatment practices of pharmacists in Montana. Dent LA; Harris KJ; Noonan CW J Am Pharm Assoc (2003); 2010; 50(5):575-9. PubMed ID: 20833614 [TBL] [Abstract][Full Text] [Related]
7. Perspectives and perceived barriers to pharmacist-prescribed tobacco cessation services in the community pharmacy setting. Xiong S; Willis R; Lalama J; Farinha T; Hamper J J Am Pharm Assoc (2003); 2021; 61(4S):S39-S48. PubMed ID: 33483273 [TBL] [Abstract][Full Text] [Related]
8. Pharmacist-led telehealth tobacco cessation services compared with usual care in a community health center. McDuffie AC; Varughese SJ; Duffy AR; Faiella AS; Wegener LF; Singer KA; Whitner JB; Valentino AS J Am Pharm Assoc (2003); 2022; 62(6):1891-1896.e2. PubMed ID: 35970728 [TBL] [Abstract][Full Text] [Related]
9. A pharmacist-delivered smoking cessation program in Qatar: an exploration of pharmacists' and patients' perspectives of the program. El Hajj MS; Sheikh Ali SAS; Awaisu A; Saleh R; Kheir N; Shami R Int J Clin Pharm; 2021 Dec; 43(6):1574-1583. PubMed ID: 34080087 [TBL] [Abstract][Full Text] [Related]
10. Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Patwardhan PD; Chewning BA Int J Pharm Pract; 2009 Aug; 17(4):221-9. PubMed ID: 20161528 [TBL] [Abstract][Full Text] [Related]
11. Pharmacist prescriptive authority for smoking cessation medications in the United States. Adams AJ; Hudmon KS J Am Pharm Assoc (2003); 2018; 58(3):253-257. PubMed ID: 29426612 [TBL] [Abstract][Full Text] [Related]
12. Bridging the Gap in Tobacco Cessation Services: Utilizing Community Pharmacists to Facilitate Transitions of Care in the USA. Newlon J; Hilts KE; Champion V; Hudmon KS J Gen Intern Med; 2022 Aug; 37(11):2840-2844. PubMed ID: 35426008 [TBL] [Abstract][Full Text] [Related]
13. Health Authority Pharmacists' Perceptions of Independent Pharmacist Prescribing. Prasad M; Loewen PS; Shalansky S; Salmasi S; Barry AR Can J Hosp Pharm; 2019; 72(3):185-193. PubMed ID: 31258163 [TBL] [Abstract][Full Text] [Related]
14. Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico. Shen X; Bachyrycz A; Anderson JR; Tinker D; Raisch DW J Manag Care Spec Pharm; 2014 Jun; 20(6):579-87. PubMed ID: 24856596 [TBL] [Abstract][Full Text] [Related]
15. Smoking cessation counseling in Qatar: community pharmacists' attitudes, role perceptions and practices. El Hajj MS; Al Nakeeb RR; Al-Qudah RA Int J Clin Pharm; 2012 Aug; 34(4):667-76. PubMed ID: 22733168 [TBL] [Abstract][Full Text] [Related]
16. Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia. Lewis J; Barry AR; Bellefeuille K; Pammett RT Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33922521 [TBL] [Abstract][Full Text] [Related]
17. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services. Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199 [TBL] [Abstract][Full Text] [Related]
18. A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee. Salwan A; Mathis SM; Brooks B; Hagemeier NE; Tudiver F; Foster KN; Alamian A; Pack RP Res Social Adm Pharm; 2024 Oct; 20(10):978-985. PubMed ID: 38981793 [TBL] [Abstract][Full Text] [Related]
19. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Herbert KE; Urmie JM; Newland BA; Farris KB Res Social Adm Pharm; 2006 Sep; 2(3):299-314. PubMed ID: 17138516 [TBL] [Abstract][Full Text] [Related]
20. A cross-sectional survey on the attitudes and interests of rural population towards expanded pharmacist prescribing in India. Khan MU; Arief M; Ahmad A; Malik S; Gogoi LJ; Kalita M; Saleem F; Hassali MA Int J Clin Pharm; 2017 Apr; 39(2):473-477. PubMed ID: 28260131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]